Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer that does not express an estrogen receptor (ER), a progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.